Sunitha M Gill, MD
Internal Medicine · Los Angeles
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 32 years
- Graduated 1994
Offices
1 location · South Central Family Health Center · 22 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Gill’s office at (323) 908-4200 to ask if they take your plan before you enroll.
California Medical Board record
Licence A84262 · Current
Licensed to practise in California · since 2003 · expires 2027-08-31 · Ntr University of Health Sciences, Gandhi Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Internal Medicine
Medicaid work
$208,284 in 2024
Medicaid paid $208,284 for 20,673 billed services this clinician did in 2024, up to 280 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 1,058 | $208,001 |
| Short return visit (20+ min) | 1,784 | $284 |
| TOBACCO USE ASSESSED | 20 | $0 |
| Current tobacco smoker (CAD, CAP, COPD, PV) (DM) | 20 | $0 |
| TOBACCO NON-USER | 1,630 | $0 |
| Pain severity quantified; pain present (COA) (ONC) | 809 | $0 |
| Pain severity quantified; no pain present (COA) (ONC) | 997 | $0 |
| Advance care planning discussion documented in the medical record (COA) | 357 | $0 |
| Medication list documented in medical record (COA) | 1,680 | $0 |
| Review of all medications by a prescribing practitioner or clinical pharmacist (such as, prescriptions, OTCs, herbal therapies and supplements) documented in the medical record (COA) | 1,680 | $0 |
| FXNL STATUS ASSESSED | 604 | $0 |
| Dilated retinal eye exam with interpretation by an ophthalmologist or optometrist documented and reviewed; with evidence of retinopathy (DM) | 50 | $0 |
| 2024 | 20,673 | 43 | 280 | $208,284 |
| 2023 | 11,280 | 35 | 179 | $124,531 |
| 2022 | 3,707 | 9 | 150 | $157,445 |
| 2021 | 2,838 | 6 | 104 | $160,835 |
| 2020 | 1,083 | 9 | 119 | $64,278 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 892 | $123,964 |
| Short return visit (20+ min) | 1,408 | $567 |
| TOBACCO USE ASSESSED | 12 | $0 |
| Current tobacco smoker (CAD, CAP, COPD, PV) (DM) | 12 | $0 |
| TOBACCO NON-USER | 788 | $0 |
| Patient screened for future fall risk; documentation of no falls in the past year or only 1 fall without injury in the past year (GER) | 15 | $0 |
| Pain severity quantified; pain present (COA) (ONC) | 287 | $0 |
| Pain severity quantified; no pain present (COA) (ONC) | 483 | $0 |
| Advance care planning discussion documented in the medical record (COA) | 461 | $0 |
| Medication list documented in medical record (COA) | 705 | $0 |
| Review of all medications by a prescribing practitioner or clinical pharmacist (such as, prescriptions, OTCs, herbal therapies and supplements) documented in the medical record (COA) | 704 | $0 |
| FXNL STATUS ASSESSED | 231 | $0 |
2022
| Clinic visit/encounter, all-inclusive | 1,173 | $156,995 |
| Short return visit (20+ min) | 1,275 | $449 |
| Blood glucose (sugar) level | 155 | $0 |
| Hemoglobin A1C level | 99 | $0 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 14 | $0 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 12 | $0 |
| Short return visit | 841 | $0 |
| Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | 102 | $0 |
| Behavioral health screening to determine eligibility for admission to treatment program | 36 | $0 |
2021
| Clinic visit/encounter, all-inclusive | 1,201 | $159,199 |
| Short return visit (20+ min) | 726 | $1,324 |
| Return visit (30+ min) | 423 | $222 |
| Short return visit | 426 | $91 |
| Blood glucose (sugar) level | 48 | $0 |
| Hemoglobin A1C level | 14 | $0 |
2020
| Clinic visit/encounter, all-inclusive | 475 | $63,104 |
| Short return visit (20+ min) | 281 | $709 |
| Return visit (30+ min) | 121 | $222 |
| Short return visit | 90 | $143 |
| Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | 14 | $100 |
| Blood glucose (sugar) level | 15 | $0 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 40 | $0 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 16 | $0 |
| OFF/OP EST MAY X REQ PHY/QHP | 31 | $0 |
Drugs they prescribed that Part D paid
$533,942
Pharmacies billed $533,942 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
1,928 generic and 572 brand-name prescriptions · $533,942 in drug cost · 18 antibiotic prescriptions to 12 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jardiance | 157 | $194,150 | $1,237 |
| Trulicity | 79 | $96,248 | $1,218 |
| Januvia | 68 | $65,393 | $962 |
| Ozempic | 44 | $52,986 | $1,204 |
| Trelegy Ellipta | 16 | $10,275 | $642 |
See all 43 drugs
| Jardiance | 157 | $194,150 | $1,237 |
| Trulicity | 79 | $96,248 | $1,218 |
| Januvia | 68 | $65,393 | $962 |
| Ozempic | 44 | $52,986 | $1,204 |
| Trelegy Ellipta | 16 | $10,275 | $642 |
| Basaglar Kwikpen U-100 | 15 | $6,860 | $457 |
| Atorvastatin | 317 | $4,332 | $14 |
| Nifedipine Er | 105 | $4,290 | $41 |
| Lantus Solostar | 38 | $3,527 | $93 |
| Humalog Kwikpen U-100 | 24 | $2,794 | $116 |
| Levothyroxine | 34 | $2,612 | $77 |
| Metformin | 206 | $2,157 | $10 |
| Amlodipine Besylate | 195 | $1,558 | $8 |
| Benazepril | 75 | $1,408 | $19 |
| Irbesartan | 54 | $1,357 | $25 |
| Omega-3 Acid Ethyl Esters | 19 | $1,153 | $61 |
| Irbesartan-Hydrochlorothiazide | 34 | $1,018 | $30 |
| Metoprolol | 47 | $923 | $20 |
| Tamsulosin | 44 | $876 | $20 |
| Albuterol Sulfate Hfa | 15 | $871 | $58 |
| Telmisartan | 24 | $777 | $32 |
| Lisinopril | 81 | $760 | $9 |
| Rosuvastatin | 30 | $709 | $24 |
| Carvedilol | 35 | $568 | $16 |
| Gabapentin | 38 | $524 | $14 |
| Losartan | 41 | $520 | $13 |
| Glipizide | 39 | $519 | $13 |
| Hydralazine | 40 | $518 | $13 |
| Chlorthalidone | 21 | $427 | $20 |
| Clopidogrel | 19 | $362 | $19 |
| Labetalol | 11 | $329 | $30 |
| Metoprolol | 32 | $309 | $10 |
| Enalapril Maleate | 11 | $275 | $25 |
| Losartan-Hydrochlorothiazide | 13 | $247 | $19 |
| Glimepiride | 31 | $247 | $8 |
| Furosemide | 37 | $232 | $6 |
| Hydrochlorothiazide | 21 | $195 | $9 |
| Finasteride | 12 | $170 | $14 |
| Lisinopril-Hydrochlorothiazide | 11 | $131 | $12 |
| Pioglitazone | 15 | $128 | $9 |
| Sertraline | 11 | $77 | $7 |
| Clonidine | 16 | $70 | $4 |
| Atenolol | 16 | $69 | $4 |
Year by year
| 2024 | 2,562 | 250 | None | 22% | $533,942 |
| 2023 | 2,343 | 291 | 0% (0) | 16% | $530,784 |
| 2022 | 2,087 | 292 | 1% (13) | 14% | $346,247 |
| 2021 | 1,101 | 214 | None | 15% | $103,717 |
| 2020 | 719 | 194 | None | 14% | $62,828 |
| 2019 | 886 | 101 | 2% (21) | None | $97,090 |
| 2018 | 728 | 96 | 4% (29) | None | $52,860 |
| 2017 | 614 | 87 | 3% (16) | 21% | $37,047 |
| 2016 | 414 | 58 | None | 22% | $25,791 |
| 2015 | 51 | 23 | None | None | $1,508 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 38 drugs
| Jardiance | 131 | $218,460 | $1,668 |
| Januvia | 56 | $73,602 | $1,314 |
| Trulicity | 28 | $48,616 | $1,736 |
| Atorvastatin | 263 | $7,472 | $28 |
| Amlodipine Besylate | 237 | $5,138 | $22 |
| Metformin | 193 | $4,862 | $25 |
| Lantus Solostar | 13 | $4,674 | $360 |
| Benazepril | 97 | $3,838 | $40 |
| Irbesartan | 67 | $3,312 | $49 |
| Nifedipine Er | 48 | $2,989 | $62 |
| Lisinopril | 87 | $2,917 | $34 |
| Hydralazine | 66 | $2,630 | $40 |
| Losartan | 86 | $2,289 | $27 |
| Chlorthalidone | 39 | $1,915 | $49 |
| Irbesartan-Hydrochlorothiazide | 33 | $1,912 | $58 |
| Tamsulosin | 29 | $1,398 | $48 |
| Telmisartan | 14 | $1,094 | $78 |
| Metoprolol | 24 | $1,093 | $46 |
| Glipizide | 35 | $942 | $27 |
| Bisoprolol | 11 | $883 | $80 |
| Levothyroxine | 24 | $732 | $30 |
| Sertraline | 26 | $703 | $27 |
| Metoprolol | 30 | $684 | $23 |
| Losartan-Hydrochlorothiazide | 18 | $637 | $35 |
| Rosuvastatin | 14 | $578 | $41 |
| Carvedilol | 24 | $577 | $24 |
| Hydrochlorothiazide | 53 | $569 | $11 |
| Furosemide | 39 | $527 | $14 |
| Diclofenac | 13 | $525 | $40 |
| Enalapril Maleate | 13 | $513 | $39 |
| Simvastatin | 19 | $468 | $25 |
| Gabapentin | 24 | $430 | $18 |
| Glimepiride | 21 | $411 | $20 |
| Clopidogrel | 12 | $406 | $34 |
| Clonidine | 16 | $351 | $22 |
| Atenolol | 19 | $342 | $18 |
| Alendronate | 11 | $324 | $29 |
| Omeprazole | 14 | $218 | $16 |
2022: 34 drugs
| Jardiance | 97 | $160,684 | $1,657 |
| Januvia | 28 | $42,792 | $1,528 |
| Trulicity | 15 | $22,227 | $1,482 |
| Basaglar Kwikpen U-100 | 22 | $7,621 | $346 |
| Atorvastatin | 246 | $5,331 | $22 |
| Omega-3 Acid Ethyl Esters | 11 | $4,251 | $386 |
| Benazepril | 94 | $3,223 | $34 |
| Amlodipine Besylate | 208 | $2,471 | $12 |
| Chlorthalidone | 48 | $2,429 | $51 |
| Enalapril Maleate | 30 | $2,231 | $74 |
| Losartan | 106 | $2,221 | $21 |
| Metformin | 150 | $2,210 | $15 |
| Hydralazine | 58 | $1,791 | $31 |
| Lisinopril | 60 | $1,204 | $20 |
| Nifedipine Er | 14 | $1,171 | $84 |
| Levothyroxine | 39 | $1,143 | $29 |
| Metoprolol | 22 | $1,001 | $45 |
| Diclofenac | 26 | $834 | $32 |
| Hydrochlorothiazide | 94 | $831 | $9 |
| Glipizide | 40 | $687 | $17 |
| Furosemide | 56 | $661 | $12 |
| Losartan-Hydrochlorothiazide | 20 | $644 | $32 |
| Tamsulosin | 23 | $611 | $27 |
| Irbesartan | 15 | $525 | $35 |
| Albuterol Sulfate Hfa | 14 | $493 | $35 |
| Metoprolol | 36 | $445 | $12 |
| Gabapentin | 31 | $439 | $14 |
| Alendronate | 22 | $429 | $20 |
| Omeprazole | 15 | $416 | $28 |
| Sertraline | 22 | $373 | $17 |
| Simvastatin | 18 | $370 | $21 |
| Carvedilol | 22 | $365 | $17 |
| Clonidine | 17 | $293 | $17 |
| Quinapril | 15 | $265 | $18 |
2021: 22 drugs
| Januvia | 30 | $37,427 | $1,248 |
| Jardiance | 11 | $16,897 | $1,536 |
| Atorvastatin | 135 | $2,565 | $19 |
| Novolin R | 16 | $2,279 | $142 |
| Losartan | 72 | $962 | $13 |
| Benazepril | 53 | $881 | $17 |
| Levothyroxine | 28 | $757 | $27 |
| Metformin | 92 | $726 | $8 |
| Albuterol Sulfate Hfa | 17 | $718 | $42 |
| Chlorthalidone | 14 | $639 | $46 |
| Amlodipine Besylate | 64 | $482 | $8 |
| Gabapentin | 25 | $426 | $17 |
| Diclofenac | 16 | $402 | $25 |
| Lisinopril | 22 | $275 | $13 |
| Glipizide | 19 | $212 | $11 |
| Famotidine | 12 | $176 | $15 |
| Simvastatin | 18 | $166 | $9 |
| Metoprolol | 18 | $163 | $9 |
| Hydrochlorothiazide | 33 | $154 | $5 |
| Alendronate | 11 | $149 | $14 |
| Furosemide | 15 | $101 | $7 |
| Omeprazole | 11 | $65 | $6 |
2020: 15 drugs
| Januvia | 14 | $14,459 | $1,033 |
| Atorvastatin | 69 | $1,372 | $20 |
| Rosuvastatin | 15 | $675 | $45 |
| Losartan | 47 | $604 | $13 |
| Amlodipine Besylate | 48 | $551 | $11 |
| Levothyroxine | 21 | $494 | $24 |
| Metoprolol | 17 | $394 | $23 |
| Metformin | 33 | $368 | $11 |
| Lisinopril | 18 | $179 | $10 |
| Omeprazole | 11 | $152 | $14 |
| Gabapentin | 17 | $146 | $9 |
| Alendronate | 13 | $110 | $8 |
| Simvastatin | 15 | $105 | $7 |
| Hydrochlorothiazide | 17 | $79 | $5 |
| Azithromycin | 11 | $67 | $6 |
2019: 19 drugs
| Xarelto | 12 | $11,382 | $948 |
| Atorvastatin | 73 | $1,620 | $22 |
| Bystolic | 11 | $1,554 | $141 |
| Levothyroxine | 47 | $1,295 | $28 |
| Losartan | 67 | $937 | $14 |
| Rosuvastatin | 16 | $831 | $52 |
| Metoprolol | 26 | $779 | $30 |
| Amlodipine Besylate | 55 | $738 | $13 |
| Potassium Chloride | 11 | $707 | $64 |
| Metformin | 57 | $681 | $12 |
| Montelukast | 12 | $466 | $39 |
| Escitalopram | 12 | $400 | $33 |
| Gabapentin | 19 | $322 | $17 |
| Simvastatin | 23 | $276 | $12 |
| Furosemide | 12 | $194 | $16 |
| Lisinopril | 28 | $182 | $6 |
| Benazepril | 12 | $164 | $14 |
| Alendronate | 13 | $150 | $12 |
| Metoprolol | 12 | $83 | $7 |
2018: 14 drugs
| Levothyroxine | 59 | $1,573 | $27 |
| Atorvastatin | 66 | $1,324 | $20 |
| Rosuvastatin | 19 | $1,181 | $62 |
| Duloxetine | 13 | $791 | $61 |
| Amlodipine Besylate | 49 | $669 | $14 |
| Losartan | 39 | $496 | $13 |
| Metformin | 50 | $433 | $9 |
| Escitalopram | 11 | $265 | $24 |
| Gabapentin | 20 | $260 | $13 |
| Hydrocodone-Acetaminophen | 11 | $194 | $18 |
| Oxycodone | 11 | $170 | $15 |
| Lisinopril | 15 | $146 | $10 |
| Simvastatin | 15 | $137 | $9 |
| Atenolol | 16 | $124 | $8 |
2017: 16 drugs
| Xarelto | 13 | $4,955 | $381 |
| Atorvastatin | 51 | $1,830 | $36 |
| Levothyroxine | 56 | $1,466 | $26 |
| Proair Hfa | 12 | $1,080 | $90 |
| Metoprolol | 27 | $561 | $21 |
| Losartan | 28 | $476 | $17 |
| Metformin | 35 | $381 | $11 |
| Amlodipine Besylate | 29 | $298 | $10 |
| Diltiazem 24hr Er | 12 | $244 | $20 |
| Lisinopril | 18 | $215 | $12 |
| Montelukast | 12 | $215 | $18 |
| Escitalopram | 12 | $211 | $18 |
| Omeprazole | 15 | $205 | $14 |
| Gabapentin | 16 | $160 | $10 |
| Simvastatin | 11 | $148 | $13 |
| Atenolol | 18 | $135 | $7 |
2016: 10 drugs
| Lantus Solostar | 11 | $4,046 | $368 |
| Metoprolol | 23 | $523 | $23 |
| Levothyroxine | 19 | $501 | $26 |
| Atorvastatin | 21 | $479 | $23 |
| Diltiazem 24hr Er | 12 | $406 | $34 |
| Amlodipine Besylate | 15 | $169 | $11 |
| Lisinopril | 16 | $155 | $10 |
| Metformin | 18 | $109 | $6 |
| Simvastatin | 19 | $91 | $5 |
| Atenolol | 13 | $45 | $3 |
Money from drug and device companies
$90 in 2024
| 2024 | 1 | 1 | None | $90 |
| 2022 | 1 | 1 | None | $12 |
| 2019 | 8 | 10 | None | $474 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Corcept Therapeutics | Korlym | $90 | 1 payment
|
See the published payment
| Corcept Therapeutics | Meals · 2024-11-16 | Korlym | $90 |
See earlier years (2022, 2019)
2022: $12
| Novo Nordisk | Saxenda | $12 | 1 payment
|
2019: $474
| Novo Nordisk | None | $312 | 2 payments
|
| Lilly USA | Trulicity | $35 | 2 payments
|
| Amgen | Evenity | $29 | 1 payment
|
| Amarin Pharma | Vascepa | $24 | 1 payment
|
| Abbott Laboratories | Freestyle Libre Pro | $22 | 1 payment
|
| GlaxoSmithKline | Anoro | $21 | 1 payment
|
| Sanofi Pasteur | Fluzone High-Dose | $18 | 1 payment
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $14 | 1 payment
|
Professional record
- NPI
- 1417044876
- Licence
- CA A84262California A84262: Current · expires 2027-08-31
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 3801 Miranda Ave, 111a, Palo Alto, CA, 94304
- NPI first listed
- 2006-10-06
- NPI last updated
- 2021-11-29
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.